Powering next-generation regenerative medical devices with material expertise, regulatory know-how and disciplined manufacturing execution
Paramus, NJ — January 21, 2026 — Regenity Biosciences announced its participation in MD&M West 2026, taking place February 3–5 at the Anaheim Convention Center in Anaheim, California. Regenity will exhibit at Booth 676 and highlight its regenerative biomaterial expertise and contract development and manufacturing capabilities supporting medical device programs from early development through scalable manufacturing.
MD&M West is an advanced manufacturing trade show that brings together companies across the medical technology industry focused on translating device concepts into manufacturable solutions.
At MD&M West 2026, Regenity will share how its integrated contract development and manufacturing capabilities support material selection, development execution, and manufacturing readiness for medical device programs, from early design considerations through production scale.
With 28 years of experience, Regenity has supported regenerative applications across a wide range of clinical settings, from wound care and orthopedics to dental, spine, neurosurgery, and nerve repair. Drawing on its collagen, bioceramics, and synthetic polymer platforms, Regenity develops bioresorbable materials designed to support tissue healing, consistent device performance, and reliable clinical outcomes.
Regenity’s participation at MD&M West reflects its continued focus on working with medical device partners to address complex material, regulatory, and manufacturing challenges while supporting consistent quality and scalable production.
To learn more about Regenity’s contract development and manufacturing capabilities or to schedule a meeting during MD&M West 2026, please contact:
Sean Stevenson
Business Development
[email protected]